Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Kamai, Takao ^a   Tomosugi, Naohisa ^b   Abe, Hideyuki ^a   Arai, Kyoko ^a   Yoshida, Ken Ichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEPCIDIN; HEPCIDIN 25; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; HEPCIDIN 25, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TISSUE DIFFERENTIATION; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 69249166103     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-270     Document Type: Article

References (39)

1. Motzer RJ Bander NH Nanus DM Renal-cell carcinoma N Engl J Med 1996, 335:865-875. 10.1056/NEJM199609193351207 8778606
2. Yagoda A Petrylak D Thompson S Cytotoxic chemotherapy for advanced renal cell carcinoma Urol Clin North Am 1993, 20:303-321. 8493752
3. Yagoda A Abi-Rached B Petrylak D Chemotherapy for advanced renal-cell carcinoma: 1983-1993 Semin Oncol 1995, 22:42-60. 7855619
4. Motzer RJ Russo P Nanus DM Berg WJ Renal cell carcinoma Current Problem Cancer 1997, 21:189-232.
5. 5Motzer RJ Bukowski RM Targeted therapy for metastatic renal cell carcinoma J Clin Oncol 2006, 24:5601-5608. 10.1200/JCO.2006.08.5415 17158546
6. Kaelin WG Jr The von Hippel - Lindau protein, HIF hydroxylation, and oxygen sensing Biochim Biophys Res Commun 2005, 338:627-638. 10.1016/ j.bbrc.2005.08.165
7. Le NT Richardson DR The role of iron in cell cycle progression and the proliferation of nepolastic cells Biochim Biophys Acta 2002, 1603:31-46. 12242109
8. Kartioglu ZA Sarper RM Rinsvelt HA Guffey JA Fink RW Trace element concentration in renal cell carcinoma Cancer 1978, 42:1330-1340. 10.1002/ 1097-0142(197809)42:3<1330::AID-CNCR2820420344>3.0.CO;2-Z 212175
9. Ganz T Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 2003, 102:783-788. 10.1182/ blood-2003-03-0672 12663437
10. Nemeth E Tuttle MS Powelson J Vaughn MB Donovan A Wardm DM Ganz T Kaplan J Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 2004, 306:2090-2093. 10.1126/ science.1104742 15514116
11. Kijima H Sawada T Tomosugi N Kubota K Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma BMC Cancer 2008, 8:1471-2407-8-167. 10.1186/1471-2407-8-167 2430575 18541040
12. Ward DG Roberts K Brookes MJ Joy H Martin A Ismail T Spychal R Iqbal T Tselepis C Increased hepcidin expression in colorectal carcinogenesis World J Gastroenterol 2008, 14:1339-1345. 10.3748/wjg.14.1339 2693679 18322945
13. Kamai T Tsujii T Arai K Takagi K Asami H Ito Y Oshima H Yoshida K-I Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer Clin Cancer Res 2003, 9:2632-2641. 12855641
14. Kamai T Yanai Y Arai K Abe H Yamanishi T Kurimoto M Yoshida K-I Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis BMC Cancer 2007, 7:1471-2407-7-159. 10.1186/1471-2407-7-159 1988828 17697365
15. Suwa H Ohshio G Imamura T Watanabe G Arii S Imamura M Narumiya S Hiai H Fukumoto M Overexpression of the rho C gene correlates with progression of ductal adenocarcinoma of the pancreas Br J Cancer 1998, 77:147-152. 9459160
16. Fuhrman SA Lasky LC Lmas C Renal cell carcinoma Current Problem Cancer 1997, 21:189-232. Am J Surg Pathol 1982, 6: 655-663.
17. Sobin H Wittekind CH editors International union against cancer. UICC TNM classification of malignant tumors New York, Wiley-Liss 6, 2002.
18. Tomosugi N Kawabata H Watanabe R Higuchi M Yamaya H Umehara H Ishikawa I Detection of serum hepcidin in renal failure and inflammation by using proteinchip system Blood 2006, 108:1381-1387. 10.1182/blood-2005-10-4043 16621968
19. Nemeth E Rivera S Gabayan V Keller C Taudorf S Pedersen BK Ganz T IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 2004, 113:1271-1276. 398432 15124018
20. Komai Y Saito K Sakai K Morimoto S Increased preoperative C-reactive protein level predicts a poor prognosis in patient with localized renal cell carcinoma BJU Int 2007, 99:77-80. 10.1111/j.1464-410X.2006.06497.x 16956357
21. Tatokoro M Saito K Iimura Y Fujii Y Kawakami S Kihara K Prognostic impact of postoperative C-reactive protein level in patients with metastatis renal cell carcinoma undergoing cytoreductive nephrectomy J Urol 2008, 180:515-519. 10.1016/j.juro.2008.04.025 18550105
22. Saito K Tatokoro M Fujii Y Iimura Y Koga F Kawakami S Kihara K Impact of C-Reactive protein kinetics on survival of patients with metastatic renal cell carcinoma Eur Urol 2008, 55:1145-1153. 10.1016/ j.eururo.2008.10.012 18930583
23. Iimura Y Saito K Fujii Y Kumagai J Kawakami S Komai Y Yonese J Fukui I Kihara K Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: The TNM-C Score J Urol 2009, 181:1004-1012. 10.1016/ j.juro.2008.10.156 19150550
24. Gabay C Kushner I Acute phase proteins and other systemic responses to inflammation N Engl J Med 1999, 340:448-454. 10.1056/NEJM199902113400607 9971870
25. Blay JY Negrier S Combaret V Attali S Goillot E Merrouche Y Mercatello A Ravault A Tourani JM Moskovtchenko JF Philip T Favrot M Serum level of Il-6 as a prognostic factor in metastatic renal cell carcinoma Cancer Res 1997, 52:3317-3322.
26. Takenawa J Kaneko Y Fukumoto M Fukatsu A Hirano T Fukuyama H Nakayama H Fujita J Yoshida O Enhanced expression of interleukin-6 in primary human renal cell carcinoma J Natl Cancer Inst 1991, 83:1668-1672. 10.1093/jnci/ 83.22.1668 1749019
27. Paule B Belot J Rudant C Coulombel C Abbou CC The importance of IL-6 protein expression in primary human renal cell carcinoma: An immunohistochemical study J Clin Pathol 2000, 53:388-390. 10.1136/ jcp.53.5.388 1731193 10889822
28. Motzer RJ Bacik J Murphy BA Russo P Mazumdar M Interferon-alpha as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J Clin Oncol 2002, 20:289-296. 10.1200/ JCO.20.1.289 11773181
29. Ganz T Olbina G Girelli D Nemeth E Westerman M Immunoassay for human serum hepcidin Blood 2008, 112:4292-4297. 10.1182/blood-2008-02-139915 18689548
30. Kulaksiz H Theilig F Bachmann S Gehrke SG Rost D Janetzko A Cetin Y Stremmel W The iron-regulatory peptide hormone hepcidin: Expression and cellular localization in the mammalian kidney J Endocrinol 2005, 184:361-370. 10.1677/joe.1.05729 15684344
31. Novick AC Open surgery of the kidney Campbell-Walsh Urology Philadelphia: Saunders Elsevier Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA 9, 2007:1686-758.
32. Quigley JP Armstrong PB Tumor cell intravasation alu-cidated; The chick embryo opens the window Cell 2007, 94:281-284. 10.1016/ S0092-8674(00)81470-1
33. Voulgari A Pintzas A Epitheal-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic Biochim Biophys Acta 2009. 19306912
34. Folkman J Tumor angiogenesis: Therapeutic implications N Engl J Med 1971, 285:1182-1186. 4938153
35. Semenza GL Targeting HIF-1 for cancer therapy Nat Rev Cancer 2003, 3:721-732. 10.1038/nrc1187 13130303
36. Linehan WM Walther MM Zbar B The genetic basis of cancer of the kidney J Urol 2003, 170:2163-2172. 10.1097/01.ju.0000096060.92397.ed 14634372
37. Pili R Donehower RC Is HIF-1 a valid therapeutic target? J Natl Cancer Inst 2003, 95:498-499. 12671009
38. Brookes MJ Boult J Roberts K Cooper BT Hotchin NA Matthews G Iqbal T Tselepis C A role for iron in Wnt signaling Oncogene 2008, 27:966-975. 10.1038/sj.onc.1210711 17700530
39. Bienz M Clevers H Linking colorectal cancer to Wnt signaling Cell 2000, 103:311-320. 10.1016/S0092-8674(00)00122-7 11057903